ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding ProQR Therapeutics N.V. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 47 | −4 |
| Shares | 22.1M | 21.2M | −890.4K (−4.0%) |
| Value | $17.2M | $15.9M | −$1.35M (−7.8%) |
New holders (8)
Institutions that held ProQR Therapeutics N.V. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DAFNA Capital Management LLC | 649,383 | $483.0K | 0.13% |
| Acadian Asset Management LLC | 187,034 | $138.0K | 0.00% |
| Raymond James & Associates | 51,161 | $38.0K | 0.00% |
| Balyasny Asset Management LLC | 21,433 | $16.0K | 0.00% |
| Csenge Advisory Group | 10,000 | $7.00K | 0.00% |
| UBS Group AG | 5,098 | $4.00K | 0.00% |
| Axiom Investment Management LLC | 4,500 | $3.00K | 0.01% |
| China Universal Asset Management Co., Ltd. | 701 | $1.00K | 0.00% |
Sold out (12)
Institutions that held ProQR Therapeutics N.V. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 209,215 | $162.0K |
| D. E. Shaw & Co., Inc. | 110,552 | $86.0K |
| Millennium Management LLC | 66,157 | $51.0K |
| Virtu Financial LLC | 61,425 | $48.0K |
| State Street Corp | 52,123 | $41.0K |
| HRT Financial LP | 46,469 | $36.0K |
| Susquehanna International Group, LLP | 39,565 | $31.0K |
| Two Sigma Securities, LLC | 27,821 | $22.0K |
| Ground Swell Capital, LLC | 21,640 | $17.0K |
| Clear Harbor Asset Management, LLC | 17,000 | $13.0K |
| JustInvest LLC | 16,660 | $13.0K |
| Captrust Financial Advisors | 7,500 | $6.00K |